|
De Romeri, V., Fernandez-Martinez, E., Gehrlein, J., Machado, P. A. N., & Niro, V. (2017). Dark Matter and the elusive Z' in a dynamical Inverse Seesaw scenario. J. High Energy Phys., 10(10), 169–21pp.
Abstract: The Inverse Seesaw naturally explains the smallness of neutrino masses via an approximate B-L symmetry broken only by a correspondingly small parameter. In this work the possible dynamical generation of the Inverse Seesaw neutrino mass mechanism from the spontaneous breaking of a gauged U(1) B-L symmetry is investigated. Interestingly, the Inverse Seesaw pattern requires a chiral content such that anomaly cancellation predicts the existence of extra fermions belonging to a dark sector with large, non-trivial, charges under the U(1) B-L. We investigate the phenomenology associated to these new states and find that one of them is a viable dark matter candidate with mass around the TeV scale, whose interaction with the Standard Model is mediated by the Z' boson associated to the gauged U(1) B-L symmetry. Given the large charges required for anomaly cancellation in the dark sector, the B-L Z' interacts preferentially with this dark sector rather than with the Standard Model. This suppresses the rate at direct detection searches and thus alleviates the constraints on Z'-mediated dark matter relic abundance. The collider phenomenology of this elusive Z' is also discussed.
|
|
|
ATLAS Collaboration(Aaboud, M. et al), Alvarez Piqueras, D., Barranco Navarro, L., Cabrera Urban, S., Castillo Gimenez, V., Cerda Alberich, L., et al. (2017). Search for new high-mass phenomena in the dilepton final state using 36 fb(-1) of proton-proton collision data at root s=13 TeV with the ATLAS detector. J. High Energy Phys., 10(10), 182–61pp.
Abstract: A search is conducted for new resonant and non-resonant high-mass phenomena in dielectron and dimuon fi nal states. The search uses 36 : 1 fb(-1) of proton-proton collision data, collected at root s = 13TeV by the ATLAS experiment at the LHC in 2015 and 2016. No signi fi cant deviation from the Standard Model prediction is observed. Upper limits at 95% credibility level are set on the cross-section times branching ratio for resonances decaying into dileptons, which are converted to lower limits on the resonance mass, up to 4.1 TeV for the E-6 -motivated Z(X)'. Lower limits on the qqll contact interaction scale are set between 2.4 TeV and 40 TeV, depending on the model.
|
|
|
Dias, J. M., Debastiani, V. R., Roca, L., Sakai, S., & Oset, E. (2017). Binding of the BD(D)over-bar and BDD systems. Phys. Rev. D, 96(9), 094007–6pp.
Abstract: We study theoretically the BD (D) over bar and BDD systems to see if they allow for possible bound or resonant states. The three-body interaction is evaluated implementing the fixed center approximation to the Faddeev equations which considers the interaction of a D or (D) over bar particle with the components of a BD cluster, previously proved to form a bound state. We find an I(J(P)) = 1/2(0(-)) bound state for the BD (D) over bar system at an energy around 8925-8985 MeV within uncertainties, which would correspond to a bottom hidden-charm meson. In contrast, for the BDD system, which would be bottom double-charm and hence manifestly exotic, we have found hints of a bound state in the energy region 8935-8985 MeV, but the results are not stable under the uncertainties of the model, and we cannot assure, nor rule out, the possibility of a BDD three-body state.
|
|
|
Ma, Y. Z., Vijande, J., Ballester, F., Tedgren, A. C., Granero, D., Haworth, A., et al. (2017). A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate Ir-192 brachytherapy. Med. Phys., 44(11), 5961–5976.
Abstract: PurposeA joint working group was created by the American Association of Physicists in Medicine (AAPM), the European Society for Radiotherapy and Oncology (ESTRO), and the Australasian Brachytherapy Group (ABG) with the charge, among others, to develop a set of well-defined test case plans and perform calculations and comparisons with model-based dose calculation algorithms (MBDCAs). Its main goal is to facilitate a smooth transition from the AAPM Task Group No. 43 (TG-43) dose calculation formalism, widely being used in clinical practice for brachytherapy, to the one proposed by Task Group No. 186 (TG-186) for MBDCAs. To do so, in this work a hypothetical, generic high-dose rate (HDR) Ir-192 shielded applicator has been designed and benchmarked. MethodsA generic HDR Ir-192 shielded applicator was designed based on three commercially available gynecological applicators as well as a virtual cubic water phantom that can be imported into any DICOM-RT compatible treatment planning system (TPS). The absorbed dose distribution around the applicator with the TG-186 Ir-192 source located at one dwell position at its center was computed using two commercial TPSs incorporating MBDCAs (Oncentra((R)) Brachy with Advanced Collapsed-cone Engine, ACE, and BrachyVision ACUROS) and state-of-the-art Monte Carlo (MC) codes, including ALGEBRA, BrachyDose, egs_brachy, Geant4, MCNP6, and Penelope2008. TPS-based volumetric dose distributions for the previously reported source centered in water and source displaced test cases, and the new source centered in applicator test case, were analyzed here using the MCNP6 dose distribution as a reference. Volumetric dose comparisons of TPS results against results for the other MC codes were also performed. Distributions of local and global dose difference ratios are reported. ResultsThe local dose differences among MC codes are comparable to the statistical uncertainties of the reference datasets for the source centered in water and source displaced test cases and for the clinically relevant part of the unshielded volume in the source centered in applicator case. Larger local differences appear in the shielded volume or at large distances. Considering clinically relevant regions, global dose differences are smaller than the local ones. The most disadvantageous case for the MBDCAs is the one including the shielded applicator. In this case, ACUROS agrees with MC within [-4.2%, +4.2%] for the majority of voxels (95%) while presenting dose differences within [-0.12%, +0.12%] of the dose at a clinically relevant reference point. For ACE, 95% of the total volume presents differences with respect to MC in the range [-1.7%, +0.4%] of the dose at the reference point. ConclusionsThe combination of the generic source and generic shielded applicator, together with the previously developed test cases and reference datasets (available in the Brachytherapy Source Registry), lay a solid foundation in supporting uniform commissioning procedures and direct comparisons among treatment planning systems for HDR Ir-192 brachytherapy.
|
|
|
LHCb Collaboration(Aaij, R. et al), Garcia Martin, L. M., Martinez-Vidal, F., Oyanguren, A., Remon Alepuz, C., Ruiz Valls, P., et al. (2017). Measurement of B-0, B-s(0), B(+)and lambda(0)(b) production asymmetries in 7 and 8 TeV proton-proton collisions. Phys. Lett. B, 774, 139–158.
Abstract: The B-0, B-s(0), B+ and lambda(0)(b) hadron production asymmetries are measured using a data sample corresponding to an integrated luminosity of 3.0 fbc(-1), collected by the LHCb experiment in proton-proton collisions at centre-of-mass energies of 7 and 8 TeV. The measurements are performed as a function of transverse momentum and rapidity of the b hadrons within the LHCb detector acceptance. The overall production asymmetries, integrated over transverse momentum and rapidity, are also determined.
|
|